Reticulocyte Count: What Young Red Cells Tell You

What Is a Reticulocyte?

Reticulocytes are immature red blood cells released from the bone marrow. A normal count means the marrow is producing red cells at the appropriate rate. An abnormal count helps doctors understand why a patient is anaemic.

Normal Reticulocyte Range

High Reticulocyte Count

Low Reticulocyte Count

Interpreting Anaemia with Reticulocyte Count

FAQs

Frequently Asked Questions

References

The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.

1. Poikilocytosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK562141

References

Sources cited on this page. PubMed links open the original abstract.

1. Bessman JD, Gilmer PR, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80(3):322–326. PMID 3998989 · doi:10.1093/ajcp/80.3.322

What reticulocytes are and why they matter

Reticulocytes are immature red blood cells released from the bone marrow into the bloodstream before they mature into fully formed erythrocytes. They contain residual ribosomal RNA (giving them a "reticulated" appearance on special staining) and lose this over 24–48 hours in circulation, after which they become mature red blood cells. Normally, reticulocytes make up 0.5–2.5% of circulating red blood cells (or approximately 50–150 × 10⁹/L in absolute terms).

The reticulocyte count answers a crucial question in anaemia investigation: Is the bone marrow responding appropriately to the anaemia, or is it failing to produce?

• High reticulocytes (reticulocytosis): Bone marrow is working hard – compensating for blood loss or red cell destruction. A raised reticulocyte count in the context of anaemia points to haemolytic anaemia or acute blood loss – both conditions where the marrow is intact but red cells are being lost faster than they can be made.
• Low or normal reticulocytes in the context of anaemia: Bone marrow production is inadequate. This "hypoproliferative" pattern is seen in iron deficiency (the marrow lacks substrate), B12/folate deficiency (megaloblastic arrest), aplastic anaemia (marrow failure), anaemia of chronic disease (inflammatory suppression of erythropoiesis), renal failure (EPO deficiency), and chemotherapy-induced suppression.

The reticulocyte production index – correcting for anaemia severity

A raw reticulocyte count is misleading without correcting for the degree of anaemia. In severe anaemia, even a "normal" absolute reticulocyte count represents an inadequate response because the stimulus (profound hypoxia) should be driving a much larger increase. The Reticulocyte Production Index (RPI) corrects for this:

RPI = (Reticulocyte % × Patient Hb) ÷ (Normal Hb × Maturation factor)

An RPI above 2–3 indicates an appropriate haemopoietic response (haemolysis, blood loss). An RPI below 2 in the context of anaemia indicates hypoproliferation – marrow failure, deficiency, or chronic disease. This distinction drives the next investigation: in haemolysis, request blood film + LDH + haptoglobin + DAT; in hypoproliferation, request iron studies + B12/folate + bone marrow biopsy if required.

Reticulocyte haemoglobin content (CHr / RetHe)

Modern analysers can measure reticulocyte haemoglobin content (CHr or RetHe) – the amount of haemoglobin inside newly produced reticulocytes. This is the earliest indicator of functional iron deficiency – a state where the body has insufficient iron available for erythropoiesis, even if total body iron stores are not yet critically depleted. CHr below 28 pg indicates iron-deficient erythropoiesis and is particularly useful in: diagnosing early iron deficiency before ferritin becomes abnormal; monitoring iron replacement therapy; and identifying functional iron deficiency in CKD patients on EPO therapy (where ferritin is often falsely elevated as an acute phase protein).